Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-25

FDA Approved: POTASSIUM ACETATE — Supplemental Application (Exela Pharma Sciences, LLC)

View source ↗

Summary

FDA approves a supplemental application for Potassium Acetate from Exela Pharma Sciences, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium Acetate (Potassium acetate)

Snippet

SUPPL AP for POTASSIUM ACETATE (POTASSIUM ACETATE)